VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
OFIX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
OFIXOrthofix Medical Inc.
$9.18$371M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksOFIXBalance Sheet

Orthofix Medical Inc. (OFIX) Balance Sheet

30Y historyFree accessUpdated daily

Total debt has increased to $234.4 million in 2026Q1 from $117.1 million in 2023Q4, driving the debt-to-equity ratio up to 0.54.

Income StatementBalance SheetCash FlowRatios

OFIX Balance Sheet

Annual statement

OFIX Balance Sheet

Orthofix Medical Inc. (OFIX) balance sheet — 30-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets446.13M416.85M433.29M420.44M255.99M269.52M270.38M260.55M244.64M251.8M194.37M212.25M256.41M282.25M340.44M404.59M311.76M299.49M274.65M280.78M233.97M207.28M162.59M147.87M137M112.41M125.73M75.63M63.5M48.5M44.5M
Cash & Short-Term Investments103.81M82.03M83.24M33.11M50.7M87.85M96.29M69.72M69.62M81.16M39.57M63.66M36.81M30.49M31.05M33.21M13.56M13.33M14.59M25.06M25.88M63.79M25.94M33.56M48.81M34.27M50.46M9.72M7M4.1M3.6M
Cash Only103.81M82.03M83.24M33.11M50.7M87.85M96.29M69.72M69.62M81.16M39.57M63.66M36.81M30.49M31.05M33.21M13.56M13.33M14.59M25.06M25.88M63.79M25.94M33.56M48.81M34.27M50.46M9.72M7M4.1M3.6M
Short-Term Investments0000000000000000000000000000000
Accounts Receivable135.82M135.75M134.71M128.1M82.86M78.56M72.42M86.81M77.75M63.44M57.85M59.84M61.36M70.81M103.8M188.07M149.12M142.66M110.72M108.9M104.66M80.75M75.32M70.69M54.65M46.11M42.2M39.76M32.7M27M24M
Days Sales Outstanding59.1660.2561.562.6265.6461.7365.0268.8862.6453.3751.5355.0955.6764.5381.95118.5696.4495.4477.7781.07104.5694.0795.91126.66112.33103.66116.89119.64114.65109.5113.47
Inventory184.47M34.17M189.45M222.17M100.15M82.97M84.64M82.4M76.85M81.33M63.35M57.56M59.85M90.58M88.74M91.25M84.59M94.62M91.19M93.95M70.39M32.85M32.9M30.71M23.47M19.25M19.18M15.63M15.8M11.9M12.3M
Days Inventory Outstanding255.2146.09272.67311.45295.88263.55303.19298.93290.28319.07263.18242.83220.84323.17374.5239.29234.41249.46218.94265.77274.44143.12151.64219.42191.14163.58246.4189.02217.62191.34212.77
Other Current Assets595K164.91M25.88M37.07M22.28M0530K684K2.57M014.37M034.42M63.76M59.8M252.97M40.37M31.92M40.23M28.35M27.39M25.73M25.94M12.24M7.8M12.78M13.89M10.52M8M5.5M4.6M
Total Non-Current Assets426.89M433.8M460.01M504.87M202.64M207.1M255.48M235.07M222M153.55M177.73M187.97M136.78M144.86M163.84M290.96M292.23M290.98M286.56M604.89M628.32M266.59M268.51M265.31M83.78M76.5M64.7M61.09M58.9M64.4M68.6M
Property, Plant & Equipment130.76M-11.09M139.8M159.06M58.23M59.25M63.61M62.73M42.84M45.14M48.92M52.31M48.55M54.61M51.36M52.12M45.53M38.69M32.66M33.44M25.31M18.99M18.33M19.17M13.84M12.58M10.12M9.57M9.1M9M9.5M
Fixed Asset Turnover6.18x-5.72x4.69x7.91x7.84x6.39x7.33x10.58x9.61x8.38x7.58x8.29x7.33x9.00x11.11x12.39x14.10x15.91x14.66x14.43x16.50x15.64x10.63x12.83x12.91x13.02x12.68x11.44x10.00x8.13x
Goodwill194.93M194.93M194.93M194.93M71.32M71.32M84.02M71.18M72.4M53.56M53.56M53.56M53.56M56.11M74.39M179.37M176.5M185.18M182.58M319.94M313.07M0000000000
Intangible Assets65.97M72.77M98.8M117.49M47.39M52.67M60.52M54.14M51.9M10.46M7.46M5.3M7.15M9.05M6.88M37.52M41.46M47.63M53.55M230.31M261.16M240.32M239.96M234.12M62.99M60.82M51.45M49.06M47.5M55.5M59M
Long-Term Investments00000000219K0321K321K306.11M0400.47M-12.29M307.4M345K2M4M4M4M000000000
Other Non-Current Assets35.23M-77.44M26.47M33.39M25.7M22.09M22.29M11.91M21.42M21.07M20.14M19.17M-297.13M7.38M-389.17M12.29M-307.4M095K427K28.78M7.28M10.23M12.02M6.94M2.85M2.76M2.46M2.3M-100K100K
Total Assets873.02M850.65M893.29M925.32M458.63M476.62M525.86M495.62M466.64M405.35M372.1M400.22M393.19M427.1M504.28M695.55M603.99M590.47M561.22M885.66M862.28M473.86M431.1M413.18M220.77M188.91M190.43M136.72M122.4M112.9M113.1M
Asset Turnover0.97x0.97x0.89x0.81x1.00x0.97x0.77x0.93x0.97x1.07x1.10x0.99x1.02x0.94x0.92x0.83x0.93x0.92x0.93x0.55x0.42x0.66x0.66x0.49x0.80x0.86x0.69x0.89x0.85x0.80x0.68x
Asset Growth %3.16%-4.77%-3.46%101.76%-3.78%-9.36%6.1%6.21%15.12%8.94%-7.03%1.79%-7.94%-15.3%-27.5%15.16%2.29%5.21%-36.63%2.71%81.97%9.92%4.34%87.15%16.86%-0.8%39.29%11.7%8.41%-0.18%8.75%
Total Current Liabilities157.01M170.48M168.63M165.22M83.62M105.83M103.9M84.88M85.91M79.41M83.44M81.99M66.44M70.05M68.8M175.41M83.53M88.05M75M73.31M61.04M78.08M45.38M52.94M37.13M38.05M43.53M28.41M26M30.3M28.5M
Accounts Payable63.53M58.39M48.8M58.36M27.6M26.46M23.12M19.89M17.99M18.11M14.35M11.21M13.22M20.67M22.57M18.23M19.8M23.3M23.86M24.71M26.05M11.6M9.51M11.57M7.56M7.87M7.9M7.23M7.8M6.3M6.3M
Days Payables Outstanding81.7778.7670.2481.8181.5484.0482.8272.1567.9571.0559.6347.2848.7973.7695.2747.8154.8661.4357.369.91101.5650.5443.8382.6561.5866.9101.587.4107.43101.3108.98
Short-Term Debt03.98M01.25M000000000016K18.82M11.31M5.54M5.24M12.05M3.41M15.27M10.13M11.13M7.38M4.72M9.96M8.87M5.4M10.9M8.6M
Deferred Revenue (Current)00000000000000082.5M0012.25M9.28M00007.03M000000
Other Current Liabilities93.35M81.08M7.1M1M021.99M24.73M48.79M46.31M9.63M3.54M5.18M3.5M3.88M0108.31M27.56M59.21M27.32M16.17M12.39M51.21M25.75M30.24M15.16M25.46M25.67M12.31M12.8M13.1M13.6M
Current Ratio2.84x2.45x2.57x2.54x3.06x2.55x2.60x3.07x2.85x3.17x2.33x2.59x3.86x4.03x4.95x2.31x3.73x3.40x3.66x3.83x3.83x2.65x3.58x2.79x3.69x2.95x2.89x2.66x2.44x1.60x1.56x
Quick Ratio1.67x2.24x1.45x1.20x1.86x1.76x1.79x2.10x1.95x2.15x1.57x1.89x2.96x2.74x3.66x1.79x2.72x2.33x2.45x2.55x2.68x2.23x2.86x2.21x3.06x2.45x2.45x2.11x1.83x1.21x1.13x
Cash Conversion Cycle232.5927.58263.93292.26279.99241.24285.39295.67284.97301.39255.08250.63227.72313.94361.19310.04275.99283.46239.41276.92277.44186.64203.73263.43241.89200.34261.8221.27224.84199.54217.26
Total Non-Current Liabilities286.83M230.13M221.54M161.36M38.15M33.86M65.1M83.11M45.34M29.34M25.18M27.92M27.11M45.87M36.39M204.97M219.57M262.15M284.16M378.42M408.61M26.9M88.54M119.46M5.7M5.43M5.39M11.12M10.2M12.8M16.9M
Long-Term Debt221.59M182.8M157.01M93.11M00000000020M20M191.19M208.69M249.13M277.53M294.59M312.06M21K67.25M99.07M44K840K854K5.38M4.2M9.4M12.9M
Capital Lease Obligations98.67M42.47M17.84M18.53M19.24M19.89M22.34M20.65M00000000000000000000000
Deferred Tax Liabilities6.08M6.08M0000011.99M0000229K13.13M11.46M9.78M8.1M6.12M4.51M75.91M95.02M25.65M17.55M16.64M2.2M1.24M1.17M1.76M1.5M1.3M1.7M
Other Non-Current Liabilities52.34M-1.23M46.69M49.72M18.91M13.97M42.76M62.46M45.34M29.34M25.18M27.92M26.66M12.74M4.93M4M2.77M6.9M2.12M7.92M1.54M1.23M3.74M3.75M3.45M3.36M3.36M3.98M4.5M2.1M2.3M
Total Liabilities443.84M400.61M390.17M326.58M121.77M139.69M169M167.99M131.24M108.75M108.63M109.91M93.56M115.92M105.18M380.38M303.1M350.2M359.15M451.72M469.65M104.98M133.93M172.4M42.82M43.48M48.92M39.52M36.2M43.1M45.4M
Total Debt234.62M229.26M179.63M117.07M21.53M24.31M24.94M22.85M0000020M20.02M210.01M220.01M254.67M282.77M306.63M315.47M15.29M77.38M110.21M7.42M5.56M10.82M14.25M9.6M20.3M21.5M
Net Debt130.81M147.24M96.39M83.97M-29.17M-63.53M-71.35M-46.87M-69.62M-81.16M-39.57M-63.66M-36.81M-10.49M-11.04M176.81M206.45M241.34M268.18M281.57M289.59M-48.5M51.44M76.65M-41.39M-28.71M-39.64M4.52M2.6M16.2M17.9M
Debt / Equity0.55x0.51x0.36x0.20x0.06x0.07x0.07x0.07x-----0.06x0.05x0.67x0.73x1.06x1.40x0.71x0.80x0.04x0.26x0.46x0.04x0.04x0.08x0.15x0.11x0.29x0.32x
Debt / EBITDA1.96x---1.14x0.98x0.89x2.36x-----1.14x0.18x3.80x1.97x2.95x-4.36x12.22x0.20x1.10x2.32x0.15x0.14x0.36x0.47x0.44x1.15x1.68x
Net Debt / EBITDA1.09x----1.55x-2.56x-2.55x-4.84x-1.43x-1.33x-0.94x-2.11x-1.90x-0.60x-0.10x3.20x1.85x2.80x-4.00x11.22x-0.63x0.73x1.61x-0.85x-0.75x-1.32x0.15x0.12x0.92x1.40x
Interest Coverage-1.83x-4.19x-3.18x-16.23x-12.75x-6.35x0.85x-220.71x27.64x98.10x-18.93x9.60x-4.80x18.30x3.22x5.20x2.63x-13.59x------------
Total Equity429.18M450.04M503.12M598.73M336.86M336.93M356.86M327.63M335.4M296.61M263.48M290.31M299.63M311.18M399.1M315.17M300.89M240.27M202.06M433.94M392.63M368.88M297.17M240.78M177.95M145.43M141.51M97.2M86.2M69.8M67.7M
Equity Growth %-37.82%-10.55%-15.97%77.74%-0.02%-5.58%8.92%-2.32%13.08%12.57%-9.24%-3.11%-3.71%-22.03%26.63%4.75%25.23%18.91%-53.44%10.52%6.44%24.13%23.42%35.3%22.36%2.77%45.59%12.76%23.5%3.1%10.08%
Book Value per Share10.4911.2813.1916.3016.7617.1118.4017.3317.7316.0314.2715.4516.2316.6420.5817.3016.8013.9711.8225.4524.2922.6518.6016.4012.129.8710.127.276.495.185.42
Total Shareholders' Equity429.18M450.04M503.12M598.73M336.86M336.93M356.86M327.63M335.4M296.61M263.48M290.31M299.63M311.18M399.1M315.17M300.89M240.27M202.06M433.94M392.63M368.88M297.17M240.78M168.08M138.1M132.99M89.57M78.7M65.1M63.9M
Common Stock4.07M3.98M3.85M3.72M2.02M1.98M1.94M1.9M1.86M1.83M1.78M1.87M1.86M1.81M1.93M1.85M1.77M1.71M1.71M1.7M1.65M1.6M1.57M1.5M1.38M1.38M1.37M1.34M000
Retained Earnings-405.04M-368.33M-276.14M-150.14M1.25M21M59.38M57.75M87.08M70.4M64.18M62.55M65.36M86.37M148.55M97.25M98.33M54.12M29.65M258.2M248.43M255.47M182.07M147.92M123.19M97.28M76.32M31.5M18.6M43.1M1.2M
Treasury Stock000000000000000000000000-5.28M-22.3M-5.84M-3.78M000
Accumulated OCI-277K618K-4.3M-1.29M-1.38M03.25M-3.04M3.3M3.79M-6.58M-6.23M-382K6.35M2.5M1.76M5.39M7.19M2.89M16.69M14.26M5.06M15.14M9.39M-2.1M-6.73M-5.57M-3.38M-9.1M-6.4M-5M
Minority Interest0000000000000000000000009.87M7.33M8.53M7.63M7.5M4.7M3.8M

Key Metrics

Growth RegimeDecelerating
ProfitabilityNegative
Balance SheetAdequate
Cash FlowBurning
Top Statement Risk

Integration and liquidity strain

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Eroding Equity Base Amid Integration

According to reported financial statements, Orthofix's retained earnings have deteriorated significantly, falling from -$150.1 million in 2023Q4 to -$389.2 million by 2026Q1, reflecting the persistent operational losses and integration costs that continue to weigh on the company's long-term equity value and overall balance sheet trajectory.

The consistent decline in retained earnings suggests that the company is struggling to convert its high-margin product portfolio into bottom-line growth. Investors should monitor whether this trend indicates a structural inability to achieve profitability or merely a temporary phase of aggressive investment in the post-merger environment.

Rising Leverage Amidst Operational Challenges

Based on recent balance sheet data, Orthofix's total debt has climbed from $117.1 million in 2023Q4 to $234.4 million in 2026Q1, causing the debt-to-equity ratio to rise from 0.20 to 0.54, which indicates a growing reliance on external financing to fund ongoing operations and integration efforts.

While the current leverage remains manageable compared to more aggressive peers, the upward trend in debt during a period of negative net income warrants caution. This shift suggests that the company is increasingly dependent on debt capital to bridge the gap between its operational cash burn and its strategic investment requirements.

Liquidity Buffer Facing Increasing Pressure

As reported in quarterly filings, the company's cash position has fluctuated significantly, reaching $120.3 million in 2026Q1, while the current ratio has remained relatively stable around 2.87, suggesting that while short-term liquidity is currently adequate, the underlying cash burn necessitates careful monitoring of future capital requirements.

The current ratio provides a superficial sense of security, but the volatility in cash balances highlights the sensitivity of the company's liquidity to operational performance. If the company fails to reach cash-flow neutrality soon, the current liquidity buffer may be depleted faster than anticipated, potentially forcing further capital raises.

Goodwill Impairment Risk Remains Elevated

Based on the provided financial data, goodwill has remained stagnant at $194.9 million since 2023Q4, which, when viewed alongside the company's persistent negative operating margins and leadership turnover, suggests a potential risk of future impairment charges that could further erode the company's already strained equity base.

The lack of movement in goodwill despite the significant operational challenges and integration difficulties may imply that the carrying value of these assets is increasingly disconnected from current market realities. Investors should consider the possibility that a future write-down could be necessary if the expected synergies from the SeaSpine merger fail to materialize.

OFIX — Frequently Asked Questions

Quick answers to the most common questions about buying OFIX stock.

What are the total assets of Orthofix Medical Inc. (OFIX)?

As of 2025, Orthofix Medical Inc. (OFIX) had total assets of $850.6M including $416.8M in current assets.

How much debt does Orthofix Medical Inc. (OFIX) have?

Orthofix Medical Inc. (OFIX) carries total debt of $229.3M, offset by $82.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Orthofix Medical Inc.?

Orthofix Medical Inc. (OFIX) has total shareholders' equity (book value) of $450.0M ($11.28 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Orthofix Medical Inc.'s current ratio and liquidity?

Orthofix Medical Inc. (OFIX) reported a current ratio of 2.45x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.